Medicine and Dentistry
Colon Carcinoma
100%
Adjuvant
100%
Hyperthermic Intraperitoneal Chemotherapy
100%
Intraperitoneal Chemotherapy
100%
Peritoneum Metastasis
100%
Thymosin Alpha1
100%
Neoplasm
18%
Immune Response
18%
Colorectal Carcinoma
18%
Recurrent Disease
9%
Cell Proliferation
9%
Tumor Cell
9%
Metastatic Carcinoma
9%
CD8 Antigen
9%
Overall Survival
9%
Immunomodulating Agent
9%
Visceral Metastasis
9%
Mitomycin
9%
Keyphrases
Colon Adenocarcinoma
100%
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
100%
Peritoneal Metastasis
100%
Thymosin-α1
100%
Sham
16%
Colorectal Carcinoma
16%
Chemotherapy Treatment
16%
Immune Response
8%
Infiltration
8%
Immunological Parameters
8%
Tumor Metastasis
8%
Clinical Parameters
8%
Overall Survival
8%
Specific Marker
8%
Antitumor Effect
8%
Tumor Cell Proliferation
8%
CD8+
8%
Antitumor Immune Response
8%
C57 Mice
8%
Abdominal
8%
Mitomycin C
8%
T Helper 1
8%
Visceral Metastases
8%
Abdominal Perfusion Pressure
8%
T-bet
8%
Immunomodulatory Molecules
8%
Omental Metastasis
8%
Novel Immunomodulators
8%
Pharmacology, Toxicology and Pharmaceutical Science
Adjuvant
100%
Colon Carcinoma
100%
Intraperitoneal Chemotherapy
100%
Peritoneum Metastasis
100%
Thymosin Alpha1
100%
Neoplasm
25%
Colorectal Carcinoma
16%
Recurrent Disease
8%
Overall Survival
8%
CD8 Antigen
8%
Immunomodulating Agent
8%
C57BL Mouse
8%
Mitomycin
8%
Visceral Metastasis
8%
Immunology and Microbiology
Adjuvant
100%
Experimental Model
100%
Thymosin Alpha1
100%
Immune Response
20%
Cell Proliferation
10%
Tumor Cell
10%
CD8
10%
Perfusion
10%
Immunomodulating Drugs
10%
Overall Survival
10%
C57BL Mouse
10%